Exelixis
EXEL
#1730
Rank
C$13.89 B
Marketcap
$49.63
Share price
1.48%
Change (1 day)
79.02%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Exelixis (EXEL) - Cost to borrow shares

Latest borrow fee for Exelixis (EXEL) shares on Interactive Brokers: 0.4081% (annualized)

Shares available to borrow: 9300000

The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

Exelixis (EXEL) - cost to borrow in the last 7 days chart

Exelixis (EXEL) - number of shares available to borrow in the last 7 days

Exelixis (EXEL) - cost to borrow from 2025 to 2023

Exelixis (EXEL) - number of shares available to borrow from 2025 to 2023

Cost to borrow for shares of similar companies or competitors

Company Cost to borrow (% year) Shares available Country
0.4702%0.4 M๐Ÿ‡ฌ๐Ÿ‡ง UK
0.2638%3.8 M๐Ÿ‡ซ๐Ÿ‡ท France
0.2859%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.4081%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.4099%6.4 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.2682%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.4081%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
1.5882%0.5 M๐Ÿ‡บ๐Ÿ‡ธ USA